Antibody Treatment Approved for Emergency Use Against Early COVID-19
Published
Nov 10 2020 at 4:37 PM GMT
Key
Points
Points
- 10, 2020 -- Eli Lilly's experimental antibody treatment for COVID-19 was given emergency approval by the US and Food Administration on Monday.
- In a statement, the FDA said its approval of the antibody treatment, called bamlanivimab.
Tags
Trending
Stats
- Published Nov 10, 2020 4:37 PM GMT